G. Paul Wright

机构：Michigan Cancer Research Consortium · ORCID：0000-0001-9299-0408

发表论文 86 篇 · 总被引 2556 次 · h-index 21

代表论文

• Neoadjuvant–Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma (2023 · New England Journal of Medicine · 被引 870)
• A Review of Melanoma Subtypes: Genetic and Treatment Considerations (2024 · Journal of Surgical Oncology · 被引 32)
• Expecting the unexpected: incidental findings at a level 1 trauma center (2023 · Emergency Radiology · 被引 7)
• 1601O 3-year survival with neoadjuvant-adjuvant pembrolizumab from SWOG S1801 (2025 · Annals of Oncology · 被引 5)
• Timing of mastectomy and the effect on the likelihood of outpatient surgery and cost savings in breast cancer patients (2023 · Surgery · 被引 5)
• A phase II randomized study of neoadjuvant pembrolizumab (P) alone or in combination with vidutolimod (V) in high-risk resectable melanoma: ECOG-ACRIN EA6194. (2025 · Journal of Clinical Oncology · 被引 4)